Presentation TCT 2017 Evaluation of Suspected Coronary Artery Disease With Non-invasive and Invasive Imaging: What Do the US Guidelines and AUC Say? Presenter: Pamela S. Douglas, Paul S. Teirstein, James K. Min October 30, 2017
Presentation TCT 2017 Evaluation of Suspected Coronary Artery Disease With Noninvasive and Invasive Imaging: What Do the Data and EU Guidelines Say? Presenter: Pamela S. Douglas, Paul S. Teirstein, Stephan Achenbach October 30, 2017
Presentation TCT 2017 PLLA-Based Biolimus A9 Elution II: From Nobori to Ultimaster Specifications and Results Presenter: Ioannis Iakovou, Gert Richardt, Shigeru Saito October 30, 2017
Presentation TCT 2017 PLLA-Based Biolimus A9 Elution I: Outcomes With the BioMatrix Family of DES Presenter: Ioannis Iakovou, Gert Richardt, Christophe Dubois October 30, 2017
Presentation TCT 2017 The Orsiro Sirolimus-eluting Stent: Outcomes From the BIOFLOW and BIORESORT Trials Presenter: Ioannis Iakovou, Gert Richardt, Clemens von Birgelen October 30, 2017
Presentation TCT 2017 MiStent and DESSOLVE III Outcomes: Are the Stent and Clinical Trial Results Unique? Presenter: Ioannis Iakovou, Gert Richardt, Robert J. de Winter October 30, 2017
Presentation TCT 2017 Case Resolution: A High-Risk Patient With Complex Mutlivessel Disease How We Treated Presenter: Issam D. Moussa, Emmanouil S. Brilakis October 30, 2017
Presentation TCT 2017 Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT Presenter: Ioannis Iakovou, Gert Richardt, Dean J. Kereiakes October 30, 2017
Presentation TCT 2017 PCI vs CABG in Multivessel Disease: What Do the US Guidelines and AUC Say? Presenter: Issam D. Moussa, Manesh R. Patel October 30, 2017
Presentation TCT 2017 Pros and Cons of Bioabsorbable Polymer-Based DES: Will They Translate Into Improved Clinical Outcomes Compared to the Best Durable Polymer-Based DES? Presenter: Ioannis Iakovou, Gert Richardt, Renu Virmani October 30, 2017
Presentation TCT 2017 PCI vs CABG in Multivessel Disease: What Do the Data and EU Guidelines Say? Presenter: Issam D. Moussa, Alfredo R. Galassi October 30, 2017
Presentation TCT 2017 Case Presentation: A High-Risk Patient With Complex Multivessel Disease PCI vs CABG? Presenter: Issam D. Moussa, Emmanouil S. Brilakis October 30, 2017
Presentation TCT 2017 BioNIR: Specifications and BIONICS/NIREUS Results in Perspective Presenter: Stephen G. Ellis, David E. Kandzari October 30, 2017
Presentation TCT 2017 Resolute and Onyx Zotarolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective Presenter: Stephen G. Ellis, David E. Kandzari, Matthew J. Price October 30, 2017
Presentation TCT 2017 Case Resolution: A Patient With Stable Angina Our Approach and Outcome Presenter: Sripal Bangalore, Manesh R. Patel, Adhir Shroff October 30, 2017
Presentation TCT 2017 Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights Presenter: Giulio G. Stefanini, Stephan Windecker, Renu Virmani October 30, 2017
Presentation TCT 2017 Promus Element Everolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective Presenter: Stephen G. Ellis, David E. Kandzari, Sigmund Silber October 30, 2017
Presentation TCT 2017 Revascularization in Stable Ischemic Heart Disease: What Do the US Guidelines and AUC Say? Presenter: Sripal Bangalore, Manesh R. Patel, David J. Maron October 30, 2017
Presentation TCT 2017 XIENCE Everolimus-Eluting Stents: Device Iterations, Randomized/Registry Outcomes Data in Perspective and the Move to Shorter DAPT Presenter: Stephen G. Ellis, David E. Kandzari, Tullio Palmerini October 30, 2017
Presentation TCT 2017 Revascularization in Stable Ischemic Heart Disease: What Do the Data and EU Guidelines Say? Presenter: Sripal Bangalore, Manesh R. Patel, Carlo Di Mario October 30, 2017